hotspot -WSS

hotspot

author：fashion 2025-08-12 09:13:47 - browse：43

By some measures, private equity investment lagged in 2023, a year marked by growing distress and high-profile downfalls among private equity-backed health care companies.

Even so, three sectors still managed to see strong deal flow and prices: med spa, cardiology, and clinical trial sites, according to a new PitchBook report analyzing private equity investments in health care services in 2023. Each of the three niches continue to generate buzz among investors, even as other areas fizzle.

It’s not that those three industries are perfect fits for private equity, it’s that the more obvious areas like autism therapists and physician practices are struggling with high interest rates and regulatory scrutiny, said Rebecca Springer, PitchBook’s lead health care analyst.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： How doctors’ personal politics affect patients

WSS

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Why you shouldn’t ask, “What country has the best health care?”

'Investigate these claims': UFO transparency at center of House hearing

How generative AI ratchets up security threats for health systems

Dems pitch expanding Medicare power to negotiate drug prices

Readout Newsletter: The latest on Novavax, Merck, Bluebird

explore

hotspot

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Philips to halt sales of sleep apnea machines in U.S.

Alkermes shareholders re

Wegovy leads to weight loss. Can it treat depression, too?

Sports medicine is finally prioritizing gender equality

Reconstructing family trees of blood cells may help predict disease

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Biden warns of ‘dark winter’ during final presidental debate

Wildfire smoke exposes gaps in outdoor worker protections

What it's like to live with paralysis for one psychologist

leisure time

Wegovy leads to weight loss. Can it treat depression, too?

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

STAT Report: Patient voices and perspectives

Roche’s Alnylam deal shows drug firms interested in heart drugs

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Dems pitch expanding Medicare power to negotiate drug prices

focus

entertainment

explore

Wikipedia